BriaCell Therapeutics BCTX Growth Metrics (2020-2026)

NASDAQ BCTX
$3.65 +0.19 (+5.56%)
As of: Oct 21, 2026 · 2:01 PM EDT
Reported Financials

BriaCell Therapeutics Quarterly Growth Metrics

Periods 22 quarters
Latest Apr 2026

BriaCell Therapeutics reported asset growth of 59.23% for the quarter ended Apr 2026. These growth metrics cover 22 quarters of results from Jul 2020 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jul2020 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Growth Ratios
Assets Growth (1y)
12,032.60%-26.65%-29.64%-36.03%-36.20%-51.58%-64.20%-79.13%-78.38%-44.07%-23.44%174.08%268.68%25.55%258.78%59.23%
Assets Growth (3y)
368.50%284.35%-53.40%-42.23%-28.47%-20.18%-30.20%-0.56%-3.07%
Assets Growth (5y)
69.96%114.35%
Assets (QoQ)
-4.31%-8.36%-9.69%-11.15%-13.00%-8.61%-31.46%-34.31%-49.28%-5.34%77.35%-10.09%81.57%27.34%-39.61%156.94%-19.42%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
294,158.90%805,908.48%121.92%-28.33%-30.18%-36.74%-48.22%-63.56%-81.36%-96.68%-95.94%-57.55%-19.71%1,231.66%1,117.25%-53.14%496.44%-44.78%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
554.74%929.75%916.06%-64.01%-75.31%-52.90%-34.59%-36.53%-58.31%-3.71%-37.49%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
42.60%251.84%449.79%-19.27%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
185.43%-7.20%-7.83%-8.75%-10.55%-15.91%-24.56%-35.79%-54.24%-85.02%-7.87%571.89%-13.44%148.53%-15.78%-74.14%1,001.82%-76.99%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-1,517.99%0.00%9,809.96%-15,141.00%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
83.58%0.00%-40.00%-6,939.05%98.99%9,809.96%-319.75%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
13.67%-70.91%-99.17%-54.59%-10.53%-228.32%-114.69%-87.29%4.65%63.04%8.55%20.01%-40.89%-101.51%-10.78%-34.58%1.99%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
3.10%-27.53%-57.55%-32.31%-14.09%-34.72%-29.57%-26.33%-9.60%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-4.67%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
65.18%8.60%-43.72%-88.71%31.06%-6.51%-11.56%-34.92%-104.79%30.35%2.68%31.31%20.62%-72.34%14.88%-20.99%-13.54%5.26%-3.41%11.89%
EBITDA Margin (QoQ)
1.87M
EBIT Growth (1y)
-1,817.90%14.22%-227.36%-136.48%-23.02%-37.68%-47.22%-57.37%-119.10%-62.58%25.15%39.40%27.06%31.44%-48.31%-61.52%-5.05%-20.42%
EBIT Growth (3y)
-272.52%-24.29%-53.37%-31.14%-25.27%-15.35%-17.79%-15.49%-18.85%-10.31%
EBIT Growth (5y)
-108.72%-9.66%
EBIT Margin (QoQ)
1.87M
EBIT (QoQ)
66.74%-42.90%-59.61%-13.06%-26.94%-3.23%16.97%-26.54%-35.74%-10.35%-15.60%6.10%37.51%10.66%-39.14%11.73%-35.18%2.70%9.51%-1.19%
EBT Growth (1y)
-1,440.57%16.06%-238.70%-128.77%-16.81%-32.69%-45.52%-59.40%-129.59%-69.89%23.06%38.17%26.93%31.21%-47.73%-60.99%-4.25%-17.24%
EBT Growth (3y)
-245.71%-23.69%-55.94%-31.13%-25.14%-15.75%-18.26%-16.64%-20.48%-11.07%
EBT Growth (5y)
-99.34%-8.82%
EBT Margin (QoQ)
1.87M
EBT (QoQ)
68.76%-49.86%-59.45%-12.45%-26.04%-1.22%18.58%-27.74%-38.23%-10.87%-17.27%5.48%37.40%10.89%-38.58%11.01%-34.43%2.89%10.26%-0.08%
EPS (Basic) Growth (1y)
219.66%96.05%-212.77%51.62%-205.61%-626.62%7.70%134.03%123.87%57.97%78.01%-201.86%-170.22%86.68%88.94%93.98%
EPS (Basic) Growth (3y)
32.03%50.60%14.06%44.86%-29.60%25.90%71.79%72.46%
EPS (Basic) (QoQ)
-200.14%86.45%-166.37%210.46%-109.90%-973.78%58.80%-141.13%31.89%-36.40%115.19%69.11%-219.96%28.66%29.62%-16.59%77.25%40.78%61.66%
EPS (Diluted) Growth (1y)
36.46%-115.78%219.66%98.83%-264.60%51.62%-205.61%-596.41%7.70%134.03%123.87%56.14%78.01%-201.86%-170.22%86.68%88.94%93.98%
EPS (Diluted) Growth (3y)
-28.83%-70.38%32.03%67.06%9.55%44.86%-29.60%25.90%71.79%72.46%
EPS (Diluted) Growth (5y)
44.64%-14.89%
EPS (Diluted) (QoQ)
-114.57%-911.99%96.55%-210.52%210.46%-109.90%-973.78%58.80%-141.13%34.72%-42.31%115.19%69.11%-219.96%28.66%29.62%-16.59%77.25%40.78%61.66%
FCF Margin (QoQ)
0.78M
Free Cash Flow Growth (1y)FCF Growth (1y)
13.67%-70.91%-99.17%-54.59%-10.53%-228.32%-114.69%-87.29%4.65%63.04%8.55%20.01%-40.89%-101.51%-10.78%-34.58%1.99%
Free Cash Flow Growth (3y)FCF Growth (3y)
3.10%-27.53%-57.55%-32.31%-14.09%-34.72%-29.57%-26.33%-9.60%
Free Cash Flow Growth (5y)FCF Growth (5y)
-4.67%
Free Cash Flow (QoQ)FCF (QoQ)
65.18%8.60%-43.72%-88.71%31.06%-6.51%-11.56%-34.92%-104.79%30.35%2.68%31.31%20.62%-72.34%14.88%-20.99%-13.54%5.26%-3.41%11.89%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-50.29%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-27.27%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
73.32%-11,260.94%
Net Cash Flow Growth (1y)NCF Growth (1y)
-116.55%-109.59%-101.83%-54.59%-54.29%-98.51%-111.86%-87.29%4.62%35.07%164.83%89.48%246.48%56.23%-257.80%12.05%-409.18%
Net Cash Flow Growth (3y)NCF Growth (3y)
-30.91%-28.54%68.36%32.72%60.77%17.37%-29.41%44.25%-62.86%
Net Cash Flow Growth (5y)NCF Growth (5y)
-25.42%
Net Cash Flow (QoQ)NCF (QoQ)
74.13%-104.89%-43.72%-35.14%-0.90%-2.99%-10.09%-34.88%-29.81%-9.92%2.68%31.31%11.63%209.74%-115.79%1,056.40%-126.41%-295.63%91.20%-3,261.94%
Net Income Growth (1y)
4,830.35%-439.55%83.45%95.98%-206.46%51.12%-437.06%638.51%4.61%134.57%48.37%-197.83%44.08%-467.85%-553.78%-42.01%-15.13%-16.26%
Net Income Growth (3y)
-263.52%-16.91%22.86%40.40%-36.94%14.66%-162.70%-95.58%15.00%-13.92%
Net Income Growth (5y)
-98.64%-34.82%
Net Income (QoQ)
-192.24%-911.99%140.53%-189.74%95.50%-145.71%-973.78%58.80%50.59%346.37%-290.20%114.93%-173.79%-366.81%-8.72%1.78%-31.15%-1.40%11.86%0.82%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-1,538.26%-439.55%510.20%95.98%-207.40%51.12%-206.46%-648.33%4.94%135.05%125.14%29.93%44.30%-457.10%-370.84%-41.28%-14.79%-16.94%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-263.10%-16.52%45.78%40.49%-17.63%15.11%-39.68%-94.94%15.29%-13.54%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-98.23%-34.67%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-192.24%-911.99%85.96%-159.12%211.43%-109.91%-973.78%58.80%-142.71%30.31%-36.40%115.19%74.12%-294.22%-8.43%2.61%-32.06%-1.31%11.90%0.79%
Net Margin (QoQ)
0.42M
Operating Income Growth (1y)Op. Inc Growth (1y)
-1,817.90%14.22%-227.36%-136.48%-23.02%-37.68%-47.22%-57.37%-119.10%-62.58%25.15%39.40%27.06%31.44%-48.31%-61.52%-5.05%-20.42%
Operating Income Growth (3y)Op. Inc Growth (3y)
-272.52%-24.29%-53.37%-31.14%-25.27%-15.35%-17.79%-15.49%-18.85%-10.31%
Operating Income Growth (5y)Op. Inc Growth (5y)
-108.72%-9.66%
Operating Income (QoQ)Op. Inc (QoQ)
66.74%-42.90%-59.61%-13.06%-26.94%-3.23%16.97%-26.54%-35.74%-10.35%-15.60%6.10%37.51%10.66%-39.14%11.73%-35.18%2.70%9.51%-1.19%
Operating Margin (QoQ)
1.87M
Profit After Tax Growth (1y)PAT Growth (1y)
-1,440.57%16.06%-238.70%-128.77%-16.81%-32.69%-45.52%-59.40%-129.59%-69.89%23.06%38.17%26.93%31.21%-47.73%-60.99%-4.25%-17.24%
Profit After Tax Growth (3y)PAT Growth (3y)
-245.71%-23.69%-55.94%-31.13%-25.14%-15.75%-18.26%-16.64%-20.48%-11.07%
Profit After Tax Growth (5y)PAT Growth (5y)
-99.34%-8.82%
Profit After Tax (QoQ)PAT (QoQ)
68.76%-49.86%-59.45%-12.45%-26.04%-1.22%18.58%-27.74%-38.23%-10.87%-17.27%5.48%37.40%10.89%-38.58%11.01%-34.43%2.89%10.26%-0.08%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-23.53%-25.01%-26.67%9.18%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-5.88%-6.25%-6.67%-7.14%-7.69%-8.34%38.96%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M592.000.00M-0.01M0.00M-0.01M-0.01M0.00M-986.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.01M-0.01M-0.01M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-740.00-69.000.00M-882.0074.000.00M0.00M0.00M0.00M-0.01M0.01M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M-0.01M-0.01M-0.02M-0.14M-0.08M-0.03M0.12M0.07M0.04M0.02M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.03M-0.01M-0.02M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M-746.000.00M0.00M0.00M-0.02M-0.12M0.04M0.03M0.01M0.00M0.01M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M-0.04M0.30M0.02M0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.32M-0.03M-0.02M0.00M-0.01M0.04M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-0.01M0.00M-0.01M0.00M-0.04M0.29M0.01M0.01M0.00M0.01M0.00M
Return on Sales [ROS] (QoQ)ROS (QoQ)
1.87M
Revenue (QoQ)
197.88%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
2,335.10%114.60%-67.25%-67.44%-39.20%-51.99%87.43%39.48%-29.21%-49.99%26.98%-42.68%10.38%-54.99%92.25%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
126.50%-19.83%-7.97%-36.15%-35.77%2.32%15.41%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
1,419.08%57.27%5.98%1.66%26.65%-76.00%5.38%89.84%0.00%-6.31%-21.58%-3.65%-29.35%137.89%-64.60%-3.00%51.20%

BriaCell Therapeutics Growth Metrics API

Pull BriaCell Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY